Paediatric Healthcare

Paediatric Healthcare Market by Treatment (Immunotherapy, Medications, Surgeries), Indication (Asthma & Allergies, Cardiac Disorders, Genetic Disorders), End-User - Global Forecast 2024-2030

360iResearch Analyst
Want to know more about the paediatric healthcare market or any specific requirement? Ketan helps you find what you're looking for.
This free PDF includes market data points, ranging from trend analysis to market estimates & forecasts. See for yourself.

[192 Pages Report] The Paediatric Healthcare Market size was estimated at USD 107.01 billion in 2023 and expected to reach USD 114.55 billion in 2024, at a CAGR 7.53% to reach USD 177.94 billion by 2030.

Paediatric Healthcare Market
To learn more about this report, request a free PDF copy

Pediatric healthcare is a branch of medicine pertaining to the provision of medical care to infants, children, and adolescents. The age range typically considered for pediatric care is from birth up to 18 years. This field of healthcare encompasses a wide range of services, including prophylactic health care for healthy children and medical care for those who are acutely and chronically ill. Growing awareness among child parents of the need for adequate treatment, supported by rising government support and initiatives to promote pediatric health, has significantly contributed to the growth of the market. In addition, increasing investments in research & development for pediatric-specific medical devices and pharmaceuticals have a positive impact on market expansion. Despite the growth, the market faces several challenges, including high costs associated with pediatric care and specialty drugs, a shortfall in pediatric healthcare professionals, and uneven access to healthcare services across different regions. Regulatory hurdles for the approval of pediatric pharmaceuticals and devices also constitute significant limitations, as does the complexity of managing diverse health issues in a pediatric population. Technological advancements in neonatal and pediatric care equipment create lucrative opportunities for market growth. Additionally, the market sees potential in expanding access through telehealth services tailored for children and in integrating AI and machine learning to improve pediatric diagnostic and treatment protocols.

Paediatric Healthcare Market - Global Forecast 2024-2030
To learn more about this report, request a free PDF copy
Treatment: Expanding usage of pediatric healthcare for immunotherapy for a myriad of health conditions

Immunotherapy represents a promising frontier in pediatric healthcare, offering targeted treatments that harness and modulate the immune system to fight diseases, particularly cancer and chronic autoimmune disorders. In the pediatric population, immunotherapy includes treatments such as monoclonal antibodies, vaccine therapy, and immune checkpoint inhibitors, which have been adapted for use in children with various malignancies and immune system dysfunctions. Medications for pediatric patients are a cornerstone of treatment for a myriad of health conditions. These medications must be carefully dosed according to the child's age, weight, and health status to minimize side effects and ensure efficacy. Drug formulations for children are often distinct from adult formulations, sometimes requiring liquid suspensions, chewable tablets, or dissolvable strips to facilitate administration. Surgeries in pediatric healthcare cater to a range of complex conditions that might be congenital or acquired. Pediatric surgeons are trained to operate on infants, children, and adolescents, ensuring that procedures are adapted to the physiological characteristics of younger patients. Common surgeries include procedures for congenital heart defects, removal of tumors, organ transplants, and corrective surgeries for orthopedic anomalies.

Indication: Growing need for effective, age-appropriate medications in pediatric healthcare to manage asthma & allergies

Asthma & allergies are common chronic conditions afflicting children. The market for pediatric asthma and allergy products is driven by the need for effective, age-appropriate medications and devices. Treatments include inhalers, nebulizers, antihistamines, and immunotherapies targeted to children's needs and physiological differences compared to adults. Cardiac disorders in the pediatric population, though less common, require specialized care and treatment options. This market segment prioritizes the availability of congenital heart defect repair devices, pediatric ventricular assist devices, and age-specific cardiac medications. Genetic disorders in children, such as cystic fibrosis, Duchenne muscular dystrophy, and rare chromosomal anomalies, have bespoke therapeutic needs. Treatment approaches include gene therapy, enzyme replacement therapies, and disease-modifying treatments. Metabolic disorders in children, such as Type 1 diabetes and inborn errors of metabolism, require continuous monitoring and lifelong management.

End-User: Growing usage of pediatric healthcare across hospitals & clinics that offer a wide range of services

Ambulatory care centers are healthcare facilities where patients receive outpatient services, including diagnosis, observation, treatment, and rehabilitation services that do not require an overnight hospital stay. For pediatric patients, these centers are particularly appealing due to their convenience, reduced cost, and less intimidating environment compared with hospitals. Homecare settings involve healthcare services provided in a patient's home. Pediatric homecare can be critical for families with children who have chronic conditions or special needs or are recovering from surgery or lengthy hospital stays. Hospitals & clinics represent one of the largest segments of pediatric healthcare providers. They offer a wide range of services from general pediatric care to specialized treatments and surgeries.

Regional Insights

In the American region, pediatric healthcare is characterized by a combination of private and public funding, with an emphasis on innovation in treatment and drug development. Consumer needs are heavily influenced by the availability of advanced healthcare infrastructure and a strong focus on preventive care. Customer purchasing behavior leans towards providers that offer comprehensive services and holistic care. Investments in pediatric research are significant, with initiatives often funded through public-private partnerships. The European Union presents a diverse healthcare landscape with varying levels of access and quality. The common trend towards equitable healthcare systems is built on universal coverage. Consumer needs in pediatric healthcare focus on integrative services that address both the physiological and psychological aspects of child development. Emerging research within EU countries often explores the efficacy of pediatric treatments and health system improvements. The European Commission supports several research initiatives and collaborations aimed at enhancing pediatric healthcare. The APAC market is rapidly growing, with government policies favoring expanded coverage and improved healthcare access for children. Countries including China, India, and Japan are seeing significant research investment, particularly in the development of pediatric drugs and vaccines.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Paediatric Healthcare Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Paediatric Healthcare Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments
  • Cortica Closes USD 75 Million in New Funding Round and Acquires Springtide Child Development

    Cortica, a provider of full-spectrum autism services led by physicians, has successfully raised USD 75 million in a funding round spearheaded by Deerfield Management and Optum Ventures. Furthermore, Cortica has broadened its influence in pediatric healthcare through the acquisition of the Melmed Center, a developmental pediatrics clinic and research institution in Arizona. Cortica's expansion now encompasses 23 integrated autism centers nationwide, indicating a significant advancement in its mission to deliver comprehensive care to children with developmental differences. [Published On: 2023-04-18]

  • Pediatric Behavioral Health Provider Bend Health Moves Out of Stealth Mode with USD 32M in Funding

    Based in Madison, Wisconsin, Bend Health, a telebehavioral health enterprise specializing in pediatric services, has successfully closed a USD 32 million funding round. This significant financial milestone propels the startup from its beginnings towards national expansion, allowing for enhancements to operational processes and the recruitment of additional clinical experts. [Published On: 2023-03-23]

  • Ipsen to Acquire Albireo Accelerating Growth in Rare Disease with Treatments for Several Pediatric Liver Diseases

    Ipsen Pharma has announced a definitive agreement to acquire Albireo, a company specializing in the development of bile-acid modulators designed to treat pediatric and adult cholestatic liver diseases. This strategic move is set to enhance Ipsen's rare disease portfolio, particularly with Albireo's flagship product, Bylvay (odevixibat), which is an FDA and EMA-approved treatment for pruritus associated with progressive familial intrahepatic cholestasis (PFIC) in young patients. [Published On: 2023-01-09]

Key Company Profiles

The report delves into recent significant developments in the Paediatric Healthcare Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, AstraZeneca PLC, Aveanna Healthcare, LLC., Becton, Dickinson and Company, bioMérieux SA, Boehringer Ingelheim International GmbH, Eisai Co., Ltd., Eli Lilly and Company, Enviva Inc., Gilead Sciences, Inc., Glaxosmithkline PLC, GP Pharm, S.A., Henin Lukinz Pvt. Ltd., Interim HealthCare Inc., Janssen Global Services LLC, Johnson & Johnson Services, Inc., Medexus Pharmaceuticals, Inc., Medtronic PLC, Merck KGaA, Novartis AG, Olympus Corporation, ORPHELIA Pharma, Pfizer Inc., Proveca Ltd., Royal Philips, Sanofi S.A, Siemens AG, Strykar Corporation, The Procter & Gamble Company, Thermo Fisher Scientific, Inc., and Viatris Inc..

Market Segmentation & Coverage

This research report categorizes the Paediatric Healthcare Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Treatment
    • Immunotherapy
    • Medications
    • Surgeries
  • Indication
    • Asthma & Allergies
    • Cardiac Disorders
    • Genetic Disorders
    • Metabolic Disorders
  • End-User
    • Ambulatory Care Centers
    • Homecare Settings
    • Hospitals & Clinics

  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

  1. Market Penetration: It presents comprehensive information on the market provided by key players.
  2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
  3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
  4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
  5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

  1. What is the market size and forecast of the Paediatric Healthcare Market?
  2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Paediatric Healthcare Market?
  3. What are the technology trends and regulatory frameworks in the Paediatric Healthcare Market?
  4. What is the market share of the leading vendors in the Paediatric Healthcare Market?
  5. Which modes and strategic moves are suitable for entering the Paediatric Healthcare Market?

Table of Contents
  1. Preface
  2. Research Methodology
  3. Executive Summary
  4. Market Overview
  5. Market Insights
  6. Paediatric Healthcare Market, by Treatment
  7. Paediatric Healthcare Market, by Indication
  8. Paediatric Healthcare Market, by End-User
  9. Americas Paediatric Healthcare Market
  10. Asia-Pacific Paediatric Healthcare Market
  11. Europe, Middle East & Africa Paediatric Healthcare Market
  12. Competitive Landscape
  13. Competitive Portfolio
  14. List of Figures [Total: 22]
  15. List of Tables [Total: 288]
  16. List of Companies Mentioned [Total: 31]
Technological Advancements Revolutionizing Paediatric Healthcare
January 1, 2024
Technological Advancements Revolutionizing Paediatric Healthcare
Imagine a world where healthcare can be delivered at the comfort of your home with one click. A world where doctors can diagnose diseases without invasive procedures or taking blood samples. The healthcare industry is rapidly growing and embracing technological advancements, making things more convenient and efficient for patients. Paediatric healthcare is one such field that has seen massive growth with the help of technology, making it possible to treat even the most complex medical conditions in children. This blog post discusses how technological advancements are revolutionizing paediatric healthcare for a better future.

Remote Patient Monitoring:

Remote patient monitoring is a revolutionary tool that enables paediatricians to monitor and track the health of their young patients virtually. With the use of wearables and connected devices, paediatricians can monitor vital signs, such as heart rate, blood pressure, oxygen levels, etc., remotely and can easily identify any changes which could indicate the onset of an illness. The data collected from these devices are analyzed and used to customize treatment plans, making it easier for paediatricians to provide better care for their patients.

Electronic Health Records (EHRs):

Electronic health records have transformed paediatric healthcare by digitizing medical records, making it easier for doctors to access patient health information from anywhere at any time. With traditional paper records, there was always the risk of misplacing or losing medical records, leading to grave consequences. The use of EHRs has eliminated this problem and sped up the diagnosis and treatment process.

Medical Imaging:

Medical imaging technology has always been an essential tool in paediatric healthcare. Advances in imaging technology, such as Magnetic Resonance Imaging (MRI) and Computerized Tomography (CT), have provided paediatricians with a non-invasive way to diagnose and monitor illnesses in children. These imaging technologies provide detailed images of internal organs and tissues, enabling paediatricians to detect any abnormalities in children, leading to timely and accurate treatments.


Telemedicine is an innovative tool that has revolutionized paediatric healthcare in recent years. Paediatricians can now connect with their patients securely and remotely, providing consultation and treatment through video conferencing. Telemedicine has proven to be a game-changer, particularly in rural areas where access to medical facilities is limited.

Artificial Intelligence:

One of the most significant technological advancements in paediatric healthcare is the use of Artificial Intelligence (AI). The use of AI can help paediatricians diagnose and predict diseases by analyzing large amounts of data, providing doctors with vital insights into the patient's condition. AI can also be used to develop personalized treatment plans for individual patients, leading to better health outcomes.

The technology marks a turning point in paediatric healthcare. Advances in technology have enabled healthcare professionals to provide earlier diagnoses, personalized treatments, and comprehensive care to children more efficiently. Remote patient monitoring, Electronic health records, medical imaging, telemedicine, and Artificial Intelligence are essential tools that have transformed paediatric healthcare. The adoption of these technologies has improved medical care, leading to better health outcomes for young patients. The future of paediatric healthcare is unquestionably bright, owing to technological advancements.

Frequently Asked Questions
  1. How big is the Paediatric Healthcare Market?
    Ans. The Global Paediatric Healthcare Market size was estimated at USD 107.01 billion in 2023 and expected to reach USD 114.55 billion in 2024.
  2. What is the Paediatric Healthcare Market growth?
    Ans. The Global Paediatric Healthcare Market to grow USD 177.94 billion by 2030, at a CAGR of 7.53%
  3. When do I get the report?
    Ans. Most reports are fulfilled immediately. In some cases, it could take up to 2 business days.
  4. In what format does this report get delivered to me?
    Ans. We will send you an email with login credentials to access the report. You will also be able to download the pdf and excel.
  5. How long has 360iResearch been around?
    Ans. We are approaching our 7th anniversary in 2024!
  6. What if I have a question about your reports?
    Ans. Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available and included in every purchase to help our customers find the research they need-when they need it.
  7. Can I share this report with my team?
    Ans. Absolutely yes, with the purchase of additional user licenses.
  8. Can I use your research in my presentation?
    Ans. Absolutely yes, so long as the 360iResearch cited correctly.